Atlas Trials

Eliminating Breast Surgery for Breast Cancer Patients With Clinical Complete Response to Neoadjuvant Systemic Therapy

Clinical trial NCT06498154 · RECRUITING

Trial details

NCT number
NCT06498154
Sponsor
Tianjin Medical University Cancer Institute and Hospital
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
2024-07-25
Primary completion
2026-12-30
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.